NasdaqGS - Delayed Quote USD
Centessa Pharmaceuticals plc (CNTA)
12.67
+0.52
+(4.28%)
At close: April 22 at 4:00:01 PM EDT
12.67
0.00
(0.00%)
After hours: April 22 at 4:32:39 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ANDERSON KAREN M Officer | Conversion of Exercise of derivative security | Feb 10, 2025 | 54,322 |
BUSH TIA L Chief Technology Officer | Sale | Feb 3, 2025 | 121,503 |
CHAO DAVID M Officer | Conversion of Exercise of derivative security | Mar 17, 2025 | 225,007 |
HUSSAIN IQBAL J General Counsel | Conversion of Exercise of derivative security | Mar 17, 2025 | 110,886 |
ROTMAN HARRIS Officer | Stock Award(Grant) | Feb 1, 2024 | 62,625 |
SAHA SAURABH Chief Executive Officer | Sale | Mar 20, 2025 | 314,017 |
WEINHOFF GREGORY M Officer | Conversion of Exercise of derivative security | Mar 25, 2025 | 134,021 |
YVER ANTOINE Officer | Sale | Jun 1, 2023 | 783,066 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
13.96
+2.87%
BPMC Blueprint Medicines Corporation
83.41
-0.91%
MRUS Merus N.V.
43.21
-0.05%
AGIO Agios Pharmaceuticals, Inc.
28.00
+2.41%
XENE Xenon Pharmaceuticals Inc.
36.73
+5.85%
CRNX Crinetics Pharmaceuticals, Inc.
31.27
+3.71%
CYTK Cytokinetics, Incorporated
37.81
-0.32%
ACLX Arcellx, Inc.
63.12
+3.59%
CGON CG Oncology, Inc.
20.48
+0.34%
VIGL Vigil Neuroscience, Inc.
1.8000
+7.14%